NCCN makes changes to its guidelines for treating fever and neutropenia
Journal of Supportive Oncology 2(4): 319 355
2004
ISSN/ISBN: 1544-6794 PMID: 15357516 Document Number: 582674
Document emailed within 1 workday
Related Documents
Mesa, R.A. 2017: New guidelines from the NCCN for polycythemia vera Clinical Advances in Hematology and Oncology: H&o 15(11): 848-850Bahnson, R.R.; Hanks, G.E.; Huben, R.P.; Kantoff, P.; Kozlowski, J.M.; Kuettel, M.; Lange, P.H.; Logothetis, C.; Pow-Sang, J.M.; Roach, M.; Sandler, H.; Scardino, P.T.; Taylor, R.J.; Urban, D.A.; Walsh, P.C.; Wilson, T.G. 2000: NCCN Practice Guidelines for Prostate Cancer Oncology 14(11a): 111-119
Mock, V.; Atkinson, A.; Barsevick, A.; Cella, D.; Cimprich, B.; Cleeland, C.; Donnelly, J.; Eisenberger, M.A.; Escalante, C.; Hinds, P.; Jacobsen, P.B.; Kaldor, P.; Knight, S.J.; Peterman, A.; Piper, B.F.; Rugo, H.; Sabbatini, P.; Stahl, C. 2000: NCCN Practice Guidelines for Cancer-Related Fatigue Oncology 14(11a): 151-161
1998: NCCN practice guidelines for the myelodysplastic syndromes. National Comprehensive Cancer Network Oncology 12(11a): 53-80
Walsh, G.L.; Winn, R.J. 1997: Baseline institutional compliance with NCCN guidelines: non-small-cell lung cancer Oncology 11(11a): 161-170
1999: NCCN practice guidelines for the management of psychosocial distress. National Comprehensive Cancer Network Oncology 13(5a): 113-147
Patel, F.; Wilken, R.; Burrall, B.; Martinez, S.; Wells, V.; King, B.; Maverakis, E. 2014: Detailed protocol for administration of intralesional IL-2 for the treatment of Stage IIIc and IV M1a metastatic melanoma based on current NCCN guidelines Dermatology Online Journal 20(11)
Carlson, R.W.; Goldstein, L.J.; Gradishar, W.J.; Lichter, A.S.; McCormick, B.; Moe, R.E.; Theriault, R.L. 1996: NCCN Breast Cancer Practice Guidelines. The National Comprehensive Cancer Network Oncology 10(11 Suppl): 47-75
1999: Update: NCCN practice guidelines for the treatment of breast cancer. National Comprehensive Cancer Network Oncology 13(5a): 41-66
Patel, M.A.; Curtis, K.; Maguire, J.H. 1999: Liposomal amphotericin B for fever and neutropenia New England Journal of Medicine 341(15): 1153; Author Reply 1154-1155
Petrilli, A.S.; Melaragno, R.; Bianchi, A.; Kusano, E.; Barros, K.V.; Silva, A.A. 1991: Fever and neutropenia in children with cancer: a new therapeutic proposal Amb: Revista da Associacao Medica Brasileira 37(4): 173-180
Rubin, M.; Hathorn, J.W.; Marshall, D.; Gress, J.; Steinberg, S.M.; Pizzo, P.A. 1988: Gram-positive infections and the use of vancomycin in 550 episodes of fever and neutropenia Annals of Internal Medicine 108(1): 30-35
Bizette, G.A.; Brooks, B.J.; Alvarez, S. 1994: Ceftazidime as monotherapy for fever and neutropenia: experience in a community hospital Journal of the Louisiana State Medical Society: Official Organ of the Louisiana State Medical Society 146(10): 448-452
Chayakulkeeree, M.; Thamlikitkul, V. 2003: Risk index for predicting complications and prognosis in Thai patients with neutropenia and fever Journal of the Medical Association of Thailand 86(3): 212-223
Chambers, S.K.; Schwartz, P.E. 1986: Neutropenia and fever in patients undergoing combination chemotherapy for malignant germ cell tumors of the ovary Obstetrics and Gynecology 68(6): 842-846
Ryan, C. 1979: Guidelines for evaluating and treating hypertension Geriatrics 34(7): 43-48
Mairuhu, A.T.A.; Brandjes, D.P.M.; van Gorp, E.C.M. 2003: Treating viral hemorrhagic fever Idrugs: the Investigational Drugs Journal 6(11): 1061-1066
Gordon, A.L.; Connolly, S.L. 2017: Treating Pain in an Established Patient: Sifting Through the Guidelines Rhode Island Medical Journal 100(10): 41-44
Frances, A.J.; Kahn, D.A.; Carpenter, D.; Docherty, J.P.; Donovan, S.L. 1998: The Expert Consensus Guidelines for treating depression in bipolar disorder Journal of Clinical Psychiatry 59 Suppl. 4: 73-79
Wiesenauer, M. 2001: Complication rate not higher than conventional treatment. "Treating scarlet fever purely with homeopathy" MMW Fortschritte der Medizin 143(15): 56